Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis

Acta Ophthalmologica Scandinavica

Volumn 74, Issue 3, 1996, Pages 280-284

  Malminiemi, Kimmo ^a   Kari, Osmo ^b   Latvala, Marja Leena ^c   Voutilainen, Raija ^d   Miettinen, Ari ^e   Jauch, Arthur ^f  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Tampere Health Center   (Finland)

^d KUOPIO UNIVERSITY HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f CIBA Vision AG   (Switzerland)

Author keywords

Bacterial conjunctivitis; Bacterial resistance; Initial loading dosage; Lomefloxacin

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; EYE DROPS; FUSIDIC ACID; GENTAMICIN; LOMEFLOXACIN; NEOMYCIN; POLYMYXIN B; SULFASOMIDINE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BURN; CLINICAL ARTICLE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLIT LAMP; TOPICAL DRUG ADMINISTRATION; TREATMENT FAILURE;

EID: 0029899410     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1996.tb00092.x     Document Type: Article

References (26)

1. van der Auvera P, Grenier P, Glupczynski Y & Pieranrd D (1989): In vitro activity of lomefloxacin in comparison with pefloxacin and ofloxacin. J Antimicrob Chemother 23: 209-219.
2. Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD & Shadomy HJ (1991): Manual of clinical microbiology. 5th edition, American Society for Microbiology, Washington DC.
3. Bezirtzoglou E & Romond C (1991): Nosocomial infections of ocular conjunctiva in newborns delivered by cesarian section. Ophthalmic Res 23: 79-83.
4. Bron AJ, Leber G, Rizk SNM, Baig H, Elkington AR, Kirby GR, Neoh C, Harden A & Leong T (1991): Ofloxacin compared to chloramphenicol in the management of external ocular infection. Br J Ophthalmol 75: 675-679.
5. Dahlhoff A (1994): Quinolone resistance in Pseudomonas aerigunosa and Staphylococcus aureus. Development during therapy and clinical significance. Infection 22 (Suppl 2): 111S-121S.
6. Dette GA & Knothe H (1989): In-Vitro-Bewertung von lomefloxacin. Arzneim Forsch / Drug Res 39: 832-835.
7. Ficker L, Kirkness C, McCartney A & Seal D (1991): Microbial keratitis - The false negative. Eye 51: 549-559.
8. Gotfried MH & Ellison WT (1992): Safety and efficacy of lomefloxacin versus ceflacor in the treatment of acute exacerbations of chronic bronchitis. Am J Med 92: 108S-113S.
9. Gwon A for the Ofloxacin trial group II (1992): Ofloxacin vs Tobramycin for the treatment of external ocular infection. Arch Ophthalmol 110: 1234-1237.
10. Hatano H, Inoue K, Shia S & Wang L (1993): Application of topical lomefloxacin against experimental Pseudomonas endophthalmitis in rabbits. Acta Ophthalmol (Copenh) 71: 666-670.
11. Hoban D, DeGagne P & Witwicki E (1989): In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum. Diag Microbiol Inf Dis 12: 83S-86S.
12. Horven I (1993): Acute conjunctivitis - A comparison of fusidic acid viscous eye drops and chloramphenicol. Acta Ophthalmol (Copenh) 71: 165-168.
13. Hoshino K, Sato K, Une T & Osada Y (1989): Inhibitory effects of quinolones on DNA gyrase of Escerichia coli and topoisomerase II of fetal calf thymus. Antimicrob Agents Chemother 33: 1816-1818.
14. Huovinen P for the Finnish study group for antimicrobial resistance (1995): Resistance rates to 25 antimicrobial agents in Finland 1994-95 (HOT-project). National Public Health Institute, Turku, Finland. Unpublished.
15. Jones RN, Aldridge KE, Barry AL, Fuchs PC & Gerlach EH (1988): Multicenter in vitro evaluation of lomefloxacin (NY-198; SC-47111), including tests against nearly 7000 bacterial isolates and preliminary recommendations for susceptibility testing. Diag Microbiol Inf Dis 10: 221-240.
16. Kodama T (1991): Penetration of NY-198 (Lomefloxacin) into the aqueous humor. Jpn Rev Ophthalmol 85: 493-495.
17. Lee K & Pien F (1993): Endophthalmitis caused by nutrient variant Streptococci after filtering bleb surgery. Ann Ophthalmol 25: 51-53.
18. Leibowitz HM (1991): Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol 112: 29S-33S.
19. Miettinen A (1995): Resistance to chloramphenicol in Tampere University Hospital. Personal communication.
20. Miller IM, Vogel R, Cook RTJ, Wittreich J & the worldwide Norfloxacin ophthalmic trial group (1992): Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. Am J Ophthalmol 113: 638-644.
21. Miyao M, Tazawa H, Motoyama M, Suzuki A & Ooishi M (1993): Intraocular penetration of current antibiotics. Acta Soc Ophthalmol Jpn 97: 318-323.
22. Ooishi M, Oomomo A, Sakaue F, Tagawa H, Miyao M, Kuriyama Y, Ikerjiri Y & Samejima S (1988): Studies on intraocular penetration of NY-198 eye drops. Acta Soc Ophthalmol Jpn 92: 1825-1832.
23. Sanders DR, Aquavella JV, Hays JC, Jackson WB, Jensen HG & Long DA (1990): New horizons in anti-infective therapy. Ocul Surg News, Suppl 1: 1-15.
24. Uchida Y (1990): Evaluation of lomefloxacin (NY-198) ophthalmic solution. A multicenter phase-two double-blind clinical trial. Jpn Rev Ophthalmol 84: 51-58.
25. Uchida Y (1991): Clinical efficacy of topical lomefloxacin (NY-198) in bacterial infections of the external eye. A multicenter double-blind phase III study. Folla Opthalomol Jpn 42: 59-70.
26. Wadsworth AN & Goa KL (1991): Lomefloxacin. A review of its antibacterial activitiy, pharmacokinetic properties, and therapeutic use. Drugs (Adis Int.) 42(6): 1018-1060.